OBJECTIVETo evaluate the effects of a bleaching gel and a whitening strip on the microleakage of three different glass-ionomer cements.

METHODSForty-five freshly extracted human premolars were used and class V cavity was prepared on the buccal and lingual surfaces. The teeth were randomly assigned to A, B and C groups and restored as follows: Conventional strengthen glass-ionomer cement (Ketac Molar Easymix), compomer (F2000) and compomer (Dyract AP). Teeth were kept in distilled water at 37 degrees C for 7 days. Then the specimens were thermocycled for 500 times. Each group was randomly divided into 3 subgroups which were treated for 21 days with one of the following: Whitening strip (14% hydrogen peroxide), bleaching gel (10% carbamide peroxide), or distilled water (control). After bleaching, the teeth were placed in a solution of basic fuchsin dye for 24 hours, then the teeth were sectioned longitudinally to evaluate the dye penetration. The depth of staining along the tooth restoration interface was recorded with a stereomicroscope.

RESULTSThere were no signicant differences between the two bleaching agents in microleakage of restorations (P>0.05). The two bleaching agents did not significantly affect the microleakage of compomer (P>0.05), whereas the microleakage of glass-ionomer cement in the experimental groups was higher than that in the control group (P<0.05).

CONCLUSIONThere are no significant differences in microleakage of restorations between bleaching gel (10% carbamide peroxide) and whitening strip (14% hydrogen peroxide). The two bleaching agents do not significantly affect the microleakage of compomer but adversely affect the microleakage of strengthen glass-ionomer cement.

Bicuspid ; Bleaching Agents ; Compomers ; Composite Resins ; Dental Leakage ; Dental Restoration, Permanent ; Glass Ionomer Cements ; Humans ; Peroxides ; Urea ; analogs & derivatives

OBJECTIVETo investigate the effects of epigallocatechin gallate (EGCG)against exercise-induced fatigue in mice.

METHODSTotal 120 mice were randomly divided into three groups and tested separately. For each test, there were 30 mice subdivided into high dose (50 mg/kg . d EGCG) and low dose (10 mg/kg . d EGCG) groups as well as saline control group(1 ml/kg . d) with 10 in each. Burden swimming, running wheel endurance, stick climbing and hypoxia tolerance exercise were used to establish fatigue mice training model in three groups. And intraperitoneal injection with different doses of EGCG per day for consecutively 28 days and the mice in the control group were treated with normal saline. After the last each test, the blood lactic acid (BLA), blood urea nitrogen (BUN), blood lactate dehydrogenase (LDH), muscle glycogen (MG) and liver glycogen (LG) of each group of mice were determined.

RESULTSEGCG treatment groups(B and C)revealed a prolonged the mice survival time of burden swimming test, hypoxia tolerance, running wheel time and the ability of stick climbing(P < 0.05 or P <0.01), and increased LDH activity and MG and LG contents, reduced contents of BLA and BUN. High dose group had an obviously increase effect than lower dose group(P <0.05).

CONCLUSIONEGCG has significant effects against exercise-induced fatigue in mice.

Animals ; Blood Urea Nitrogen ; Catechin ; analogs & derivatives ; pharmacology ; Exercise Tolerance ; Fatigue ; drug therapy ; Glycogen ; metabolism ; L-Lactate Dehydrogenase ; blood ; Mice ; Physical Conditioning, Animal

Ten pharmacophore models of beta-tubulin inhibitors were established from the training set of seventeen beta-tubulin inhibitors (two categories) with comformer analysis by using the Catalyst software. The optimal pharmacophore model with two hydrophobic units and two hydrogen bond acceptor units were confirmed (RMS = 0.43, Correl = 0.98, Weight = 2.06, Config = 15.97). This pharmacophore model is able to predict the activity of known beta-tubulin inhibitors and can be further used to identify structurally diverse compounds with higher activity.
Benzamides ; chemistry ; Computer-Aided Design ; Drug Design ; Models, Chemical ; Models, Molecular ; Molecular Conformation ; Molecular Structure ; Software ; Structure-Activity Relationship ; Tubulin Modulators ; chemistry ; Urea ; analogs & derivatives ; chemistry

OBJECTIVETo establish an in vitro pig iliac artery endothelial cells (PIECs) senescence model using carbamide peroxide (CP).

METHODSMTT assay and DAPI staining were used to define the optimal concentration of CP for inducing to the PIECs senescence model. Cellular morphology, MTT assay, EdU labeling, SA-β-gal staining and cell scratch test were performed to analyze the cell growth kinetic, proliferative activity, aging ratio and migratory activity difference post CP induction. PI signal staining flow cytometry was used to analyze the cell cycle distribution difference of cells before and after CP induction.

RESULTSThe optimal CP concentration was 40 µmol/L to induce PIECs senescence. After 1 h treatment with 40 µmol/L CP, the PIECs presented typical aging form with lager and more rounded shapes. Compared with control group, the proliferative activity and the migratory distance of CP group were significantly decreased; the SA-β-gal staining positive ratio was significantly increased; the data of mitotic cycle distribution with flow cytometry analysis showed that most cells were arrested at G(1)/G(0) phase.

CONCLUSIONCP could efficiently induce pig iliac artery endothelial cell senescence in vitro.

Animals ; Cells, Cultured ; Cellular Senescence ; drug effects ; Endothelial Cells ; cytology ; drug effects ; Endothelium, Vascular ; cytology ; drug effects ; Models, Cardiovascular ; Peroxides ; pharmacology ; Swine ; Urea ; analogs & derivatives ; pharmacology

Medium- and short-chain acyl-CoA dehydrogenase deficiency is a disorder of fatty acid β-oxidation. Gene mutation prevents medium- and short-chain fatty acids from entry into mitochondria for oxidation, which leads to multiple organ dysfunction. In this study, serum acylcarnitines and the organic acid profile in urea were analyzed in two children whose clinical symptoms were hypoglycemia and metabolic acidosis. Moreover, gene mutations in the two children and their parents were evaluated. One of the patients was a 3-day-old male who was admitted to the hospital due to neonatal asphyxia, sucking weakness, and sleepiness. The serum acylcarnitine profile showed increases in medium-chain acylcarnitines (C6-C10), particularly in C8, which showed a concentration of 3.52 μmol/L (reference value: 0.02-0.2 μmol/L). The analysis of organic acids in urea gave a normal result. Sanger sequencing revealed a reported c.580A>G (p.Asn194Asp) homozygous mutation at exon 7 of the ACADM gene. The other patient was a 3-month-old female who was admitted to the hospital due to cough and recurrent fever for around 10 days. The serum acylcarnitine profile showed an increase in serum C4 level, which was 1.66 μmol/L (reference value: 0.06-0.6 μmol/L). The analysis of organic acids in urea showed an increase in the level of ethyl malonic acid, which was 55.9 (reference value: 0-6.2). Sanger sequencing revealed a reported c.625G>A (p.Gly209Ser) homozygous mutation in the ACADS gene. This study indicates that screening tests for genetic metabolic diseases are recommended for children who have unexplained metabolic acidosis and hypoglycemia. Genetic analyses of the ACADM and ACADS genes are helpful for the diagnosis of medium- and short-chain acyl-CoA dehydrogenase deficiency.
Acyl-CoA Dehydrogenase ; deficiency ; genetics ; Carnitine ; analogs & derivatives ; blood ; Female ; Humans ; Infant ; Infant, Newborn ; Lipid Metabolism, Inborn Errors ; genetics ; Male ; Mutation ; Urea ; analysis

OBJECTIVE: To investigate the genetic characterization of 3-hydroxyisovalerylcarnitine (C5-OH) metabolic abnormality in neonates. METHODS: Fifty two newborns with increased C5-OH, C5-OH/C3 and C5-OH/C8 detected by tandem mass spectrometry during neonatal screening were enrolled in the study. Genomic DNA was extracted from the whole blood samples of 52 cases and their parents. Seventy-nine genes associated with genetic and metabolic diseases including , were targeted by liquid capture technique. Variation information of these genes was examined by high-throughput sequencing and bioinformatic analysis, and then was classified based on the American College of Medical Genetics and Genomics (ACMG) standards and guidelines. The genetic types were classified as wild-type, -maternal-mutation, -paternal-mutation and -mutation. Wilcoxon rank-sum test was performed for the increased multiples of C5-OH calculated in neonatal screening. RESULTS: Twenty one variants (14 novel) were identified in 37 cases, 6 variants (5 novel) in 4 cases. The increased multiple of C5-OH calculated in -maternal-mutation and -mutation groups were significantly higher than that in wild-type group (all <0.05), while there was no significant difference between MCCC1-paternal-mutation group and wild-type group (>0.05). CONCLUSIONS Mutations on and genes are the major genetic causes for the increased C5-OH in neonates, and maternal single heterozygous mutation can contribute to the moderately to severely increased C5-OH.
Carbon-Carbon Ligases ; genetics ; Carnitine ; analogs & derivatives ; metabolism ; Female ; Genetic Testing ; Genetic Variation ; Humans ; Infant, Newborn ; Male ; Mutation ; Neonatal Screening ; Urea Cycle Disorders, Inborn ; genetics

Antineoplastic Agents/therapeutic use* ; Gastrointestinal Stromal Tumors/drug therapy* ; Humans ; Liver ; Liver Neoplasms/drug therapy* ; Lung ; Naphthyridines/therapeutic use* ; Urea/analogs & derivatives*

OBJECTIVETo evaluate the effect of carbamide peroxide (CP) bleaching agents at different concentrations and with different carriers on the micro-leakage of composite resin interface.

METHODSClass V cavity (2 mm in diameter and 2 mm in depth) preparations were made at the enamelo-cemental junction on the buccal and lingual surfaces of 35 extracted human premolars. The cavities were filled with hybrid composite resin. The teeth were stored for 24 h in distilled water at 37 degrees celsius; before thermocyling for 500 times between 5 and 55 degrees celsius;. The teeth were then randomly assigned into 7 groups, and in groups 1-6, the bleaching gels containing 10% or 20% of CP were applied on the buccal and lingual surface of the teeth for two weeks (6-8 h/day, 37 degrees celsius;, 100% relative humidity) using Carbopol, PVP or Poloxamer as the thickening carriers, respectively. The seventh group served as the control without bleaching treatment. Nail polish was applied to the surface of the tooth, and all the teeth were immersed in ammoniacal silver nitrate solution followed by developing solution. The teeth were finally sectioned through the midline of the restoration and observed under stereomicroscope. SEM micrographs were also made to observe the interface.

RESULTSWith the same bleaching agent, the micro-leakage in the gingival wall was slightly greater than in the occlusive wall, but the difference was not significant. Only 20% CP with Poloxamer as the thickening agent significantly increased the leakage of dentine-resin composite interface, and 10% and 20% CP with Carbopol or PVP as the thickening agents and 10% CP with Poloxamer produced minimal effects on filling the micro-leakage.

CONCLUSIONThickening carriers and the concentration of CP (20% or below) have no significant effect on micro-leakage of composite resin.

Bicuspid ; Bleaching Agents ; chemistry ; Composite Resins ; chemistry ; Dental Caries ; therapy ; Dental Leakage ; chemically induced ; Dental Restoration, Permanent ; methods ; Humans ; Peroxides ; chemistry ; Tooth Bleaching ; adverse effects ; Urea ; analogs & derivatives ; chemistry

In the study, the inhibitory effect of epigallocatechin gallate (EGCG) on Calcium oxalate nephrolithiasis and its possible mechanism were investigated. The rat Calcium oxalate nephrolithiasis model was induced through the combined oral administration of ethylene glycol and ammonium chloride, which was intervened with EGCG. Rat blood samples were collected to detect blood creatinine (Cr), blood urea nitrogen (BUN) and blood calcium. Rat urine samples were collected to observe and compare 24-hour urine volume, oxalic acid (Ox) and calcium in urine. Renal samples were collected to prepare tissue slices and observe the pathological changes in Calcium oxalate nephrolithiasis. The expression of osteopontin (OPN) in renal tissues was evaluated by Real-time PCR and Western blot. According to the results, compared with normal rats, rats in the nephrolithiasis model showed significant increases in Cr, BUN, urine Calcium, urine Ox and renal OPN expression (P < 0.05), but obvious decrease in 24-hour urine volume (P < 0.05); Compared with rats with nephrolithiasis, those processed with EGCG revealed remarkable declines in Cr, BUN, urine Calcium and urine Ox (P < 0.05), with significant rise in 24-hour urine volume (P < 0.05) in a concentration-dependent manner. Additionally, compared with the control group, nephrolithiasis rats showed significant pathological changes in Calcium oxalate calculus. After ECCG treatment, the renal pathological changes and OPN expression attenuated significantly in a concentration-dependent manner. The results showed that EGCG inhibits the formation of calcium oxalate nephrolithiasis in rats and shows a notable protective effect on renal functions.
Animals ; Blood Urea Nitrogen ; Calcium ; blood ; Calcium Oxalate ; metabolism ; Catechin ; administration & dosage ; analogs & derivatives ; Creatinine ; blood ; Disease Models, Animal ; Humans ; Kidney ; drug effects ; metabolism ; Male ; Nephrolithiasis ; blood ; drug therapy ; genetics ; Osteopontin ; genetics ; metabolism ; Rats ; Rats, Wistar

The present study was aimed to investigate the effects of orexin-A and orexin-1 receptor (OX1R) antagonist injected into the fourth ventricle of rats on food-intake and spontaneous physical activity (SPA). Obese rat model was induced by high fat diet. Different doses of orexin-A or SB334867, an OX1R antagonist, were injected into the fourth ventricle of obese and normal rats respectively. SPA and food intake were monitored for 4 h after injection in both light and dark environment. In the light measurement cycle, different doses of orexin-A significantly stimulated feeding and SPA in all injected rats, and the animals' responses showed a dose-dependent manner (P < 0.05-0.01), and compared with those of normal rats, the orexin-A induced food intake and SPA were more pronounced in obese rats. In the dark measurement cycle, different doses of orexin-A had no obvious effect on food intake and SPA in both normal and obese rats (P > 0.05). In the light cycle, different doses of SB334867 significantly decreased food intake and SPA in all rats during 0-2 h and 2-4 h after injection (P < 0.05), but the food intake and SPA in obese rats were significantly greater than those of normal rats. In the dark cycle, different doses of SB334867 showed no obvious effect on food intake and SPA of normal and obese rats (P > 0.05). These results suggest that fourth cerebral ventricle nuclei may be one target for orexin-A and light condition may play an important role in orexin-A and OX1R physiological functional processes.
Animals ; Benzoxazoles ; pharmacology ; Diet, High-Fat ; Eating ; drug effects ; Fourth Ventricle ; Motor Activity ; drug effects ; Obesity ; Orexin Receptor Antagonists ; pharmacology ; Orexin Receptors ; Orexins ; pharmacology ; Rats ; Urea ; analogs & derivatives ; pharmacology